摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-β-(4'-trifluoromethyl)-N-methylbenzamido-14-hydroxy-17-(cyclopropylmethyl)nordesmorphine | 1204240-08-3

中文名称
——
中文别名
——
英文名称
6-β-(4'-trifluoromethyl)-N-methylbenzamido-14-hydroxy-17-(cyclopropylmethyl)nordesmorphine
英文别名
N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-N-methyl-4-(trifluoromethyl)benzamide
6-β-(4'-trifluoromethyl)-N-methylbenzamido-14-hydroxy-17-(cyclopropylmethyl)nordesmorphine化学式
CAS
1204240-08-3
化学式
C29H31F3N2O4
mdl
——
分子量
528.571
InChiKey
YQIAWCIKPHGCLL-RDGDOILBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    38
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    73.2
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • STABLE TABLET CONTAINING 4,5-EPOXYMORPHINAN DERIVATIVE
    申请人:Ohta Kotoe
    公开号:US20120114752A1
    公开(公告)日:2012-05-10
    The present invention relates to a stable tablet comprising a 4,5-epoxymorphinan derivative or a pharmacologically acceptable acid addition salt thereof as an effective ingredient. That is, the tablet according to the present invention comprises: (1) as the effective ingredient, a specific 4,5-epoxymorphinan derivative or a pharmacologically acceptable acid addition salt; (2) sodium thiosulfate; (3) at least one selected from the group consisting of saccharides and sugar alcohols; and (4) crospovidone, sodium carboxymethyl starch or a mixture thereof, in which tablet the content of the aforementioned (4) is 1 to 20% by weight per unit weight containing the aforementioned effective ingredient.
查看更多